Promising biotech firm names new president, CEO

E. Russell McAllister succeeds Kevin Sill as the leader of Intezyne.

  • By Business Observer Staff
  • | 6:00 a.m. March 19, 2018
  • | 0 Free Articles Remaining!
  • Tampa Bay-Lakeland
  • Share

TAMPA — E. Russell McAllister is the new president and CEO of Intezyne, a clinical-stage biopharmaceutical company headquartered at the USF Tampa Bay Technology Incubator.

E. Russell McAllister. Courtesy photo.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news
Subscribe

Already subscribed? Sign in.

Latest News

  • December 19, 2025
Popular Utah dirty soda chain opening in Fort Myers
  • December 19, 2025
St. Armands receives $13.5M to address flooding concerns
  • December 18, 2025
Kolter, Casto buy 19 acres in Parrish
  • December 18, 2025
Tampa Museum of Art director to retire

Sponsored Content